Wondering how to use Ultragenyx in a sentence? Below are 10+ example sentences from authentic English texts. .
Ultragenyx in a sentence
Using Ultragenyx
- In the example corpus, ultragenyx often appears in combinations such as: ultragenyx pharmaceutical, of ultragenyx.
Context around Ultragenyx
- Average sentence length in these examples: 18 words
- Position in the sentence: 3 start, 8 middle, 0 end
- Sentence types: 11 statements, 0 questions, 0 exclamations
Corpus analysis for Ultragenyx
- In this selection, "ultragenyx" usually appears in the middle of the sentence. The average example has 18 words, and this corpus slice is mostly made up of statements.
- Around the word, pharmaceutical and released stand out and add context to how "ultragenyx" is used.
- Recognizable usage signals include shares of ultragenyx pharmaceutical by and ultragenyx pharmaceutical inc. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "ultragenyx" sits close to words such as aadi, aakash and aayush, which helps place it inside the broader word index.
Example types with ultragenyx
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. (9 words)
Ultragenyx released strong Q4 '18 results with a successful commercial launch of Crysvita and Mepsevii. (15 words)
Franklin Resources Inc. boosted its holdings in Ultragenyx Pharmaceutical by 13.3% in the fourth quarter. (16 words)
Finally, Morgan Stanley set a $83.00 price target on Ultragenyx Pharmaceutical and gave the stock a “buy” rating in a report on Monday, June 17th. (26 words)
NumerixS Investment Technologies Inc purchased a new stake in shares of Ultragenyx Pharmaceutical during the 2nd quarter valued at $25,000. (21 words)
Smith Asset Management Group LP grew its stake in shares of Ultragenyx Pharmaceutical by 22.6% in the 2nd quarter. (20 words)
Example sentences (11)
Franklin Resources Inc. boosted its holdings in Ultragenyx Pharmaceutical by 13.3% in the fourth quarter.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company.
Fred Alger Management LLC lifted its position in shares of Ultragenyx Pharmaceutical by 111.0% during the first quarter.
Ultragenyx Pharmaceutical Inc. published this content on and is solely responsible for the information contained therein.
Bank of Montreal Can lifted its position in shares of Ultragenyx Pharmaceutical by 100.9% during the fourth quarter.
Barclays reaffirmed a “buy” rating on shares of Ultragenyx Pharmaceutical in a research report on Thursday, May 9th.
Finally, Morgan Stanley set a $83.00 price target on Ultragenyx Pharmaceutical and gave the stock a “buy” rating in a report on Monday, June 17th.
First Mercantile Trust Co. raised its position in shares of Ultragenyx Pharmaceutical by 101.0% during the 1st quarter.
NumerixS Investment Technologies Inc purchased a new stake in shares of Ultragenyx Pharmaceutical during the 2nd quarter valued at $25,000.
Smith Asset Management Group LP grew its stake in shares of Ultragenyx Pharmaceutical by 22.6% in the 2nd quarter.
Ultragenyx released strong Q4 '18 results with a successful commercial launch of Crysvita and Mepsevii.
Common combinations with ultragenyx
These word pairs occur most frequently in English texts:
- ultragenyx pharmaceutical 11×
- of ultragenyx 6×